Compare · COR vs NUS
COR vs NUS
Side-by-side comparison of Cencora Inc. (COR) and Nu Skin Enterprises Inc. (NUS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COR and NUS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR is the larger of the two at $62.60B, about 265.2x NUS ($236.1M).
- COR has been more active in the news (10 items in the past 4 weeks vs 5 for NUS).
- COR has more recent analyst coverage (25 ratings vs 4 for NUS).
- Company
- Cencora Inc.
- Nu Skin Enterprises Inc.
- Price
- -
- -
- Market cap
- $62.60B
- $236.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- 1996
- News (4w)
- 10
- 5
- Recent ratings
- 25
- 4
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Nu Skin Enterprises Inc.
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Latest COR
- Executive Vice President Campbell Elizabeth S sold $3,662,663 worth of shares (11,300 units at $324.12), decreasing direct ownership by 37% to 19,455 units (SEC Form 4)
- RBC Capital Mkts initiated coverage on Cencora with a new price target
- Cencora Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form 10-Q filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Cencora Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Reports Fiscal 2026 Third Quarter Results
- Director Nally Dennis M was granted 113 shares, increasing direct ownership by 0.86% to 13,188 units (SEC Form 4)
- Director Cooper Ellen was granted 97 shares, increasing direct ownership by 12% to 893 units (SEC Form 4)
- Director Tyler Lauren M was granted 97 shares, increasing direct ownership by 2% to 4,456 units (SEC Form 4)
Latest NUS
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Nu Skin Enterprises Inc.
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Nu Skin Enterprises Reports Second Quarter Results
- Nu Skin Enterprises Announces Quarterly Dividend
- Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
- Director Winett James M was granted 26,643 shares and sold $40,481 worth of shares (7,203 units at $5.62) as part of a pre-agreed trading plan, increasing direct ownership by 108% to 37,448 units (SEC Form 4)
- Director Nathanson Laura was granted 26,643 shares, increasing direct ownership by 87% to 57,116 units (SEC Form 4)
- Director Zorko Mark A was granted 26,643 shares, increasing direct ownership by 78% to 60,586 units (SEC Form 4)
- Director Woodbury Edwina D was granted 26,643 shares and sold $41,057 worth of shares (7,203 units at $5.70) as part of a pre-agreed trading plan, increasing direct ownership by 45% to 62,433 units (SEC Form 4)